Anti-CA125 x Anti-HER2 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CA125 and anti-HER2 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can bind two factors simultaneously. It is designed for the research of Breast cancer; Gastric cancer; Prostate cacncer; Ovarian cancer; Solid tumors therapy.
There are currently no customer reviews or questions for Anti-CA125 x Anti-HER2 Bispecific Antibody (IgG-IgG) (BSIG-025). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS